Institutional Ownership
Edgewise Therapeutics Inc
CUSIP 28036F105COMEWTXQ1 2026
Institutional Holders
208
13F filers
Shares Held
113.59M
Aggregate institutional
Institutional Value
$3.56B
Q1 2026
Net New Holders
+15
37 new · 22 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions37
Increased65
Decreased66
Sold out22
Institutional Holders
208 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 15.52M | $488.83M | 0 | Held |
| 2 | Ra Capital Management, L.P. | 10.43M | $328.50M | 0 | Held |
| 3 | Paradigm Biocapital Advisors LP | 7.37M | $232.00M | +823.8K | Added |
| 4 | Baker Bros. Advisors LP | 6.58M | $207.14M | 0 | Held |
| 5 | Blackrock, Inc. | 6.47M | $203.90M | −157.6K | Reduced |
| 6 | Janus Henderson Group PLC | 5.92M | $186.29M | +1.35M | Added |
| 7 | Novo Holdings A/S | 5.35M | $168.53M | 0 | Held |
| 8 | Driehaus Capital Management LLC | 4.48M | $141.06M | +286.7K | Added |
| 9 | Siren, L.L.C. | 4.43M | $139.55M | −99.7K | Reduced |
| 10 | Perceptive Advisors LLC | 4.42M | $139.36M | −34.0K | Reduced |
198 more institutional holders on Premium
See every fund holding Edgewise Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders